The UK medical authorities also cited an exploratory analysis in which it was discovered that the dose produced a good immune response against the two most prevalent Omicron sub-variants at the time, BA.4 and BA.5.
Digital Desk: The Covid variant, Omicron's vaccination has been approved in Britain for the first time. According to Reuters, the UK pharmaceutical authority (MHRA) has authorised Moderna's "bivalent" vaccination as a booster shot for adults.
Clinical trial data that indicated the booster elicited "a significant immune response" against both Omicron (BA.1) and the original 2020 virus, according to the EPA, served as the foundation for its conclusion.
The UK medical authorities also cited an exploratory analysis in which it was discovered that the dose produced a good immune response against the two most prevalent Omicron sub-variants at the time, BA.4 and BA.5.
Continue Reading
